Cervical cancer screening and prevention in Kazakhstan and Central Asia
暂无分享,去创建一个
C. Chan | Azliyati Azizan | Talshyn Ukybassova | Askhat Balykov | G. Aimagambetova | Kuralay Kongrtay | Balkenzhe Imankulova
[1] J. Brotherton. Impact of HPV vaccination: Achievements and future challenges☆ , 2019, Papillomavirus research.
[2] A. Biggeri,et al. Estimating the impact of an organised screening programme on cervical cancer incidence: A 26‐year study from northern Italy , 2018, International journal of cancer.
[3] Saule K Balmagambetova,et al. Results of a Survey Concerning Cervical Cancer Risk Factors among Women in Western Kazakhstan , 2018, Current Perspectives in Human Papillomavirus.
[4] L. Kostrikis,et al. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing , 2018, Viruses.
[5] D. Kaidarova,et al. Screening for Cervical Cancer in Kazakhstan , 2018, Journal of Global Oncology.
[6] Azliyati Azizan,et al. Epidemiology of HPV Infection and HPV-Related Cancers in Kazakhstan: a Review , 2018, Asian Pacific journal of cancer prevention : APJCP.
[7] M. Poljak,et al. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. , 2013, Vaccine.
[8] M. Poljak,et al. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. , 2013, Vaccine.